Riptide Ventures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Vita Therapeuticsvitatx.cominOct 2022 · $31M
HealthtechBaltimore, US
Douglas Falk(Executive Officer, Director)inVlad Coric(Director)Pat LaVecchia(Director)
PartnerMike Leffer· solo GP
Co-investorsEarly Light VenturesMaryland TEDCOTEDCO
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.